InMode Ltd. Stock

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
18.5 USD -0.80% Intraday chart for InMode Ltd. +7.62% -16.82%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 480M Sales 2025 * 517M Capitalization 1.57B
Net income 2024 * 163M Net income 2025 * 183M EV / Sales 2024 * 1.25 x
Net cash position 2024 * 968M Net cash position 2025 * 1.19B EV / Sales 2025 * 0.73 x
P/E ratio 2024 *
9.86 x
P/E ratio 2025 *
8.78 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.80%
1 week+7.62%
Current month+7.62%
1 month-5.37%
3 months-26.03%
6 months-6.00%
Current year-16.82%
More quotes
1 week
16.72
Extreme 16.72
18.95
1 month
16.72
Extreme 16.72
19.40
Current year
16.72
Extreme 16.72
26.80
1 year
16.72
Extreme 16.72
48.25
3 years
16.72
Extreme 16.72
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 08-01-01
Chief Executive Officer 71 08-01-01
Director of Finance/CFO 46 16-12-31
Members of the board TitleAgeSince
Director/Board Member 89 19-08-06
Chief Executive Officer 71 08-01-01
Founder 57 08-01-01
More insiders
Date Price Change Volume
24-05-07 18.5 -0.80% 1,185,601
24-05-06 18.65 +5.73% 1,554,694
24-05-03 17.64 +1.61% 1,596,228
24-05-02 17.36 +0.70% 2,644,287
24-05-01 17.24 +0.29% 1,571,454

Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.5 USD
Average target price
25.6 USD
Spread / Average Target
+38.38%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW